APA
AZN icon

Astoria Portfolio Advisors’s AstraZeneca AZN Stock Holding History

Astoria Portfolio Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$460K Buy
2,426
+376
+18% +$70.7K 0.08% 202
2026
Q1 		$384K Buy
+2,050
New +$395K 0.08% 184
2025
Q4 		– Sell
-2,170
Closed -$370K – 294
2025
Q3 		$370K Buy
2,170
+1
+0% +$151 0.1% 170
2025
Q2 		$320K Hold
2,169
– – 0.09% 179
2025
Q1 		$297K Sell
2,169
-17
-0.8% -$2.46K 0.1% 169
2024
Q4 		$286K Hold
2,186
– – 0.1% 162
2024
Q3 		$338K Hold
2,186
– – 0.12% 137
2024
Q2 		$341K Sell
2,186
-9
-0.4% -$1.35K 0.12% 120
2024
Q1 		$302K Buy
2,195
+2
+0.1% +$265 0.12% 123
2023
Q4 		$294K Hold
2,193
– – 0.12% 124
2023
Q3 		$278K Sell
2,193
-27
-1% -$3.69K 0.13% 129
2023
Q2 		$301K Buy
2,220
+37
+2% +$5.44K 0.12% 143
2023
Q1 		$307K Sell
2,183
-287
-12% -$38.6K 0.13% 138
2022
Q4 		$342K Buy
2,470
+289
+13% +$36.2K 0.16% 124
2022
Q3 		$239K Buy
2,181
+1
+0% +$127 0.16% 137
2022
Q2 		$288K Hold
2,180
– – 0.21% 113
2022
Q1 		$289K Buy
2,180
+20
+0.9% +$2.4K 0.23% 88
2021
Q4 		$252K Buy
+2,160
New +$254K 0.2% 119

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Astoria Portfolio Advisors's AZN Position: Q2 2026 in Review

Astoria Portfolio Advisors increased its AstraZeneca (AZN) stake by 18% in Q2 2026, buying an estimated $70.7K and bringing the position to 2,426 shares worth $460K. The position accounts for 0.08% of the portfolio, ranked #202.

Astoria Portfolio Advisors first reported a position in AZN in Q4 2021 and has held it in 18 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Astoria Portfolio Advisors held 2,426 shares of AstraZeneca worth $460K as of Q2 2026.
  • Astoria Portfolio Advisors bought 376 AstraZeneca shares in Q2 2026, an estimated $70.7K.
  • AstraZeneca made up 0.08% of Astoria Portfolio Advisors's portfolio in Q2 2026, its #202 holding.
  • Astoria Portfolio Advisors first reported a position in AstraZeneca in Q4 2021 and has held it in 18 quarters since.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Astoria Portfolio Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.